caffeine has been researched along with mazindol in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Evans, SM; Johanson, CE | 1 |
Altschuler, S; Conte, A; Marlin, RL; Sebok, M; Winick, C | 1 |
Bray, GA; Greenway, FL; Rood, JC; Ryan, DH; Smith, SR; Tucker, EW | 1 |
Chen, JF; Schwarzschild, MA; Xu, K; Xu, YH | 1 |
1 trial(s) available for caffeine and mazindol
Article | Year |
---|---|
Three controlled trials of weight loss with phenylpropanolamine.
Topics: Adolescent; Adult; Appetite Depressants; Blood Pressure; Body Weight; Caffeine; Clinical Trials as Topic; Diethylpropion; Double-Blind Method; Drug Combinations; Humans; Mazindol; Middle Aged; Obesity; Phenylpropanolamine; Pulse | 1982 |
4 other study(ies) available for caffeine and mazindol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Amphetamine-like effects of anorectics and related compounds in pigeons.
Topics: Amphetamines; Animals; Appetite Depressants; Bupropion; Caffeine; Chlorphentermine; Columbidae; Dextroamphetamine; Discrimination Learning; Dose-Response Relationship, Drug; Fenfluramine; Mazindol; Propiophenones; Propylamines; Theophylline | 1987 |
Pharmaceutical cost savings of treating obesity with weight loss medications.
Topics: Adolescent; Adult; Appetite Depressants; Caffeine; Cardiovascular Diseases; Diabetes Mellitus; Drug Costs; Ephedrine; Female; Fenfluramine; Humans; Hyperlipidemias; Hypertension; Male; Mazindol; Middle Aged; Obesity; Phentermine; Risk Factors; Weight Loss | 1999 |
Caffeine's neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity shows no tolerance to chronic caffeine administration in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Binding Sites; Caffeine; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Drug Administration Schedule; Drug Tolerance; Male; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Motor Activity; Neostriatum; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Neurotoxins; Parkinsonian Disorders; Purinergic P1 Receptor Antagonists; Radioligand Assay; Receptor, Adenosine A2A; Receptors, Purinergic P1; Tritium | 2002 |